Malaria-Experienced
Showing 1 - 25 of 4,682
Plasmodium Falciparum Trial in Kisumu (RTS, S/AS01B, RTS, S/AS02A, Rabipur (Rabies) Vaccine)
Completed
- Plasmodium Falciparum
- RTS, S/AS01B
- +2 more
-
Kisumu, KenyaU.S. Army Research Unit-Kenya
Feb 10, 2021
Plasmodium Falciparum Infection Trial in Ouagadougou (drug, biological, other)
Completed
- Plasmodium Falciparum Infection
- Artesunate
- +2 more
-
Ouagadougou, Kadiogo, Burkina FasoCentre National de Recherche et de Formation sur le Paludisme -
Jul 25, 2019
ERASE - Impact of COVID-19 on Malaria Control
Not yet recruiting
- Malaria
- Malaria in Pregnancy
- Advanced Analysis of Polymorphism
- (no location specified)
Apr 25, 2022
Malaria Trial in Bamako (Chloroquine Phosphate, PfSPZ Challenge, Pyrimethamine)
Completed
- Malaria
- Chloroquine Phosphate
- +4 more
-
Bamako, MaliMalaria Vaccine Center STTB/MRTC
Jun 21, 2022
Malaria Trial in Mbabane (dihydroartemisinin-piperaquine (DHAp), reactive case detection)
Completed
- Malaria
- dihydroartemisinin-piperaquine (DHAp)
- reactive case detection
-
Mbabane, SwazilandSwaziland Ministry of Health
Aug 30, 2021
Malaria Trial in Bamako (PfSPZ Vaccine, Normal Saline, artemether 20mg/lumefantrine 120mg (AL))
Completed
- Malaria
- PfSPZ Vaccine
- +2 more
-
Bamako, MaliMalaria Research and Training Center
Aug 19, 2021
MALARIA Trial in Niamey (Artemether-lumefantrine)
Completed
- MALARIA
-
Niamey, NigerProgramme National de Lutte Contre Le Paludisme
Oct 5, 2021
Malaria Trial in Nampula (Chemopreventive Agent - SPAQ, Control Test - no drugs given)
Not yet recruiting
- Malaria
- Chemopreventive Agent - SPAQ
- Control Test - no drugs given
-
Nampula, Mozambique
- +1 more
Dec 23, 2021
Malaria Trial in Bagamoyo (Maytenus Senegalensis)
Enrolling by invitation
- Malaria
- Maytenus Senegalensis
-
Bagamoyo, TanzaniaBagamoyo Clinical Trial Facility
Jun 21, 2021
Plasmodium Falciparum Trial run by the (NMRC-M3V-Ad-PfCA, NMRC-MV-Ad-PfC, NMRC-M3V-Ad-PfCA)
Completed
- Plasmodium Falciparum
- NMRC-M3V-Ad-PfCA
- NMRC-MV-Ad-PfC, NMRC-M3V-Ad-PfCA
-
Bethesda, MarylandNaval Medical Research Center (NMRC) Clinical Trials Center
Apr 28, 2021
Malaria, Pregnancy Malaria, Cardiotoxicity Trial in Handeni (sulfadoxine-pyrimethamine (SP), dihydroartemisinin-piperaquine
Completed
- Malaria
- +4 more
- sulfadoxine-pyrimethamine (SP)
- dihydroartemisinin-piperaquine (DHA-PQP)
-
Handeni, Tanga Region, TanzaniaHandeni District Hospital
Feb 1, 2021
Malaria Trial in Nanoro (Amodiaquine Sulfadoxine-Pyrimethamin administration, Dihydroartemisinin-Piperaquine, Standard HRP2-RDT)
Not yet recruiting
- Malaria
- Amodiaquine Sulfadoxine-Pyrimethamin administration
- +3 more
-
Nanoro, Boulkiemdé, Burkina FasoInstitut de Recherche en Sciences de la Santé/ Clinical Research
Mar 23, 2021
Malaria Trial in Lambaréné (Vaccine AnAPN1)
Not yet recruiting
- Malaria
- Vaccine AnAPN1
-
Lambaréné, Moyen- Ogooué, GabonCentre de Recherches Médicales de Lammbaréné
Jun 21, 2023
Malaria, Falciparum Trial in Kisumu (FMP1/AS02A, RabAvert)
Completed
- Malaria, Falciparum
- FMP1/AS02A
- RabAvert
-
Kisumu, Nyanza Province, KenyaWalter Reed Project, Kombewa Clinic
Feb 10, 2021
Malaria Trial in Oshogbo (Perennial Malaria Chemoprevention effect)
Active, not recruiting
- Malaria
- Perennial Malaria Chemoprevention effect
-
Oshogbo, Osun, NigeriaMinistry of Health
Nov 30, 2023
Plasmodium Falciparum Malaria, Plasmodium Vivax Malaria Trial in Bangkok (Case Management and Follow-up, Reactive focal mass
Recruiting
- Plasmodium Falciparum Malaria
- Plasmodium Vivax Malaria
- Case Management and Follow-up
- Reactive focal mass drug administration (rfMDA)
-
Bangkok, ThailandDivision of Vector Born Diseases, Ministry of Health
Mar 22, 2022
Malaria Trial (BNT165e, Placebo)
Not yet recruiting
- Malaria
- BNT165e
- Placebo
- (no location specified)
Sep 29, 2023
Malaria Trial (Plasmodium falciparum Malaria Protein 010 (FMP010), Rabipur)
Completed
- Malaria
- Plasmodium falciparum Malaria Protein 010 (FMP010)
- Rabipur
- (no location specified)
Feb 10, 2021
Malaria, Malaria,Falciparum, Parasitic Disease Trial in Oxford (RH5.1 and/or RH5.2-VLP with Matrix-M)
Not yet recruiting
- Malaria
- +4 more
- RH5.1 and/or RH5.2-VLP with Matrix-M
-
Oxford, Oxfordshire, United KingdomCentre for Clinical Vaccinology & Tropical Medicine (CCVTM)
Jul 27, 2023
Malaria Trial in Kampala (long lasting insecticidal nets with chlorfenapyr-pyrethroid (PermaNet Dual), long lasting insecticidal
Not yet recruiting
- Malaria
- long lasting insecticidal nets with chlorfenapyr-pyrethroid (PermaNet Dual)
- +2 more
-
Kampala, UgandaInfectious Diseases Research Collaboration
Jul 18, 2023
Severe Malaria, Uncomplicated Malaria, Asyptomatic Plasmodium Infection Trial
Not yet recruiting
- Severe Malaria
- +2 more
- (no location specified)
Oct 6, 2023
l Antimalarial Drugs, Malaria Vaccines, and Controlled Human
Recruiting
- Malaria
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
LLIN, PBO LLIN, IRS, Larviciding Trial in Irvine, Homa Bay (Regular long-lasting insecticidal nets, LLIN plus Piperonyl
Recruiting
- LLIN, PBO LLIN, IRS, Larviciding
- Regular long-lasting insecticidal nets
- +3 more
-
Irvine, California
- +1 more
Feb 1, 2023
Uncomplicated Plasmodium Falciparum Malaria Trial in Congo, The Democratic Republic of the (Artesunate-amodiaquine,
Recruiting
- Uncomplicated Plasmodium Falciparum Malaria
-
Kapolowe, Haut-Katanga, Congo, The Democratic Republic of the
- +7 more
Oct 7, 2023